The different diseases should each be diagnosed and treated based on their specific genetic faults.
The drug inventing world can be a dog eat dog world, we take a look at the top tricks used by drug makers to squeeze the most money out of their inventions.
An alteration impairing the expression of certain proteins might hide the genesis of part of brain dysfunctions observed in schizophrenia patients.
New research suggests that financial stress may cause migraines in people who have a specific variation in a gene that regulates our biological clock.
Translational Software Inc. pharmacogenomic application integrates real-time genomic decision support at the point of care.
Researchers have found a common variant in a gene that predisposes people to developing muscle aches, regardless of whether they are taking statins
AstraZeneca has stepped up its investment in messenger RNA drugs by spending more than 25 million euros on a research alliance with biotech start-up Ethris.
New study shows that the drug cladribine leads to improved quality of life in MS patients, but the drug is blocked by EU regulators.
ASHG: This year’s Presidential Symposium will feature a discussion of global health and genomics between two absolute legends in health & science.